Stock Events

Stock Events

ABVC BioPharma 

$0.8645
31
+$0.04+4.79% Wednesday 20:00
-$0.08-9.15%Wednesday 23:30After hours

Statistics

Day High
0.877
Day Low
0.8506
52W High
3.4
52W Low
0.707
Volume
8,968
Avg. Volume
-
Mkt Cap
23.04M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Oct 13
$2.93
Apr 13
$2.83
Apr 13
$0.40
Jan 13
$3.97
Jan 13
$0.54
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

16NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.16
-0.13
-0.09
-0.06
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-7.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABVC. It's not an investment recommendation.
Coca-Cola
9
KO
Apple
8
AAPL
Alphabet
8
GOOGL
Realty Income
7
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurodegenerative diseases, similar to ABVC BioPharma's interest in psychiatric and neurological disorders.
Alkermes
ALKS
Mkt Cap7.95B
Alkermes works on central nervous system (CNS) diseases, aligning with ABVC's research in psychiatric and neurological conditions.
AMGEN
AMGN
Mkt Cap233.78B
Amgen has a broad portfolio that includes treatments for neurological disorders, competing in the same therapeutic area as ABVC.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong focus on Alzheimer's disease, which is a key area of research for ABVC BioPharma.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a diversified portfolio that includes CNS treatments, making it a competitor in ABVC's market space.
Merck
MRK
Mkt Cap366B
Merck is involved in developing therapies for Alzheimer's disease, directly competing with ABVC's research interests.
Novartis
NVS
Mkt Cap292.35B
Novartis has a significant presence in neuroscience, including treatments for neurological conditions that ABVC also targets.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the neurology and psychiatry sectors.
Rogers
ROG
Mkt Cap2.24B
Roche, with its strong focus on neuroscience and Alzheimer's disease research, competes in similar therapeutic areas as ABVC.

About

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Show more...
CEO
Uttam Yashwant Patil
Employees
19
Country
United States
ISIN
US00091F3047

Listings

XNAS
US
ABVC
BOATS
BOATS
ABVC.BOATS

0 Comments

Share your thoughts

FAQ

What is ABVC BioPharma stock price today?▼
The current price of ABVC is $0.86 USD — it has increased by +4.79% in the past 24 hours. Watch ABVC BioPharma stock price performance more closely on the chart.
What is ABVC BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ABVC BioPharma stocks are traded under the ticker ABVC.
Is ABVC BioPharma stock price growing?▼
ABVC stock has risen by +8.65% compared to the previous week, the month change is a -16.88% fall, over the last year ABVC BioPharma has showed a -68.1% decrease.
What is ABVC BioPharma market cap?▼
Today ABVC BioPharma has the market capitalization of 23.04M
When is the next ABVC BioPharma earnings date?▼
ABVC BioPharma is going to release the next earnings report on November 16, 2026.
What is ABVC BioPharma revenue for the last year?▼
ABVC BioPharma revenue for the last year amounts to 0 USD.
What is ABVC BioPharma net income for the last year?▼
ABVC net income for the last year is -7.91M USD.
Does ABVC BioPharma pay dividends?▼
Yes, ABVC dividends are paid quarterly. The last dividend per share was 2.93 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does ABVC BioPharma have?▼
As of September 03, 2026, the company has 19 employees.
In which sector is ABVC BioPharma located?▼
ABVC BioPharma operates in the Health & Wellness sector.
When did ABVC BioPharma complete a stock split?▼
The last stock split for ABVC BioPharma was on July 25, 2023 with a ratio of 1:10.
Where is ABVC BioPharma headquartered?▼
ABVC BioPharma is headquartered in FREMONT, United States.